Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
ADCT - REVENUE
Revenue ADCT - ADC Therapeutics SA
69.6 M
LAST VALUE
43.21%
2 YEAR CAGR
127.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR